Form 4: Disc Medicine CEO Exercises Stock Options
SEC Form 4 Filing
Disc Medicine's CEO, John D. Quisel, exercised stock options on July 8, 2024, acquiring 3,000 shares of common stock at $1.01 per share.
Summary
- On July 8, 2024, John D. Quisel, the CEO of Disc Medicine, Inc., exercised stock options.
- This transaction involved the acquisition of 3,000 shares of common stock at a price of $1.01 per share.
- Following the transaction, Quisel directly owns 72,065 shares of common stock.
- Quisel also holds options for 238,211 shares of common stock.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a routine disclosure of stock option exercise. The CEO exercising options is generally a positive sign, but it's not a major event.
Positives
- The CEO's exercise of stock options could be seen as a positive signal, indicating confidence in the company's future performance.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.
Stakeholder Impact
- The transaction may have a minor positive impact on shareholder sentiment due to the CEO's increased stake in the company.
Key Dates
| Date | Description |
|---|---|
| 07/08/2024 | Date of stock option exercise and common stock acquisition. |
| 07/10/2024 | Date of signature on the Form 4 filing. |
| 03/10/2030 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.